Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Starved of News, Press Speculates on Deals for Abbott, Pfizer and Wyeth
- New Year is a slow news period, which is why the business press filled up with next-to-useless corporate strategy stories about Abbott Labs, Wyeth and Pfizer. The one thing these stories all have in common? They're long on speculation and short on substance. Let's take them one at a time....
- Blog posts 2009-01-05
Additional Resources
- Joseph Mahady
- Joseph Mahady has been chosen as president of global business of Wyeth Pharmaceuticals. He also is senior vice president at Wyeth.
- Research articles 2007-03-19
- People in the News
- Joseph M. Mahady, 54, was named president of Wyeth Pharmaceuticals effective Jan. 1. Mahady, who lives in Radnor, vowed to keep expanding the Madison, N.J., company's core drugs, including Enbrel for inflammatory diseases, while developing new products. Mahady was president of global business at Wyeth Pharmaceuticals. He said the U.S....
- Research articles 2007-12-03
- Wyeth Q2 2009 Earnings Call Transcript
- Question-and-Answer Session Operator Thank you. Operator Instructions Your first question comes from Tim Anderson - Sanford Bernstein. Tim Anderson - Sanford Bernstein I have a single question for you, I guess, which is when we're going to learn the results of your go/no go decision for Phase III...
- Earnings calls 2009-07-23
- Wyeth CEO Got 69% Pay Raise; Was "Required" to Use Helicopter; Plus $24 Million Pfizer Sale Bonus
- Wyeth CEO Bernard Poussot received a 69 percent compensation raise in 2008, to $21.3 million, in addition to a $24 million change-in-control bonus for selling his company to Pfizer.* Wyeth also took the explanation of executive perks to new levels, saying that Wyeth "requires" Poussot to travel...
- Blog posts 2009-03-30
- NEWS: Update
- Wyeth promoted Joe Mahady to SVP, Wyeth and president, global business. He assumes operational responsibility for the global pharma business, including EMEA, Asia/ Pacific and Wyeth Nutrition, in addition to his responsibilities for the Americas and the company's strategic global business units.
- Research articles 2007-04-01
- Wyeth Q4 2007 Earnings Call Transcript
- Question-and-Answer Session[Operator Instructions]. Your first question comes from the line of David Risinger from Merrill Lynch. Please go ahead. David Risinger - Merrill Lynch Yes, thanks very much. Could you please comment in some detail on the change of control provision if there is one associated with your Alzheimer's...
- Earnings calls 2008-01-31
- As Layoffs Begin, Wyeth Execs Get $75 Million Severance Package
- The top five executives at Wyeth will receive $75 million between them in the Pfizer acquisition, according to an analysis by Equilar, a corporate compensation consultancy. The jackpot payouts come as their plan calls for 19,500 of their colleagues to be made jobless, and the merger they negotiated was paid...
- Blog posts 2009-02-09
- Wyeth Q1 2009 Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions Your first question comes from [Doug Subleman] - Sanford Bernstein [Doug Subleman] - Sanford Bernstein Can we get an update on when we might see the Prevnar 13 data in adults for the Phase three program, and is that likely to occur before the end...
- Earnings calls 2009-04-29
- Wyeth changes
- Two executive vice presidents and a senior vice president have been named at Wyeth. Kenneth Martin and Bernard Poussot have been appointed executive vice presidents. Martin was also named chief financial officer, and Poussot was picked as president of Wyeth Pharmaceuticals. Joseph Mahady has been selected senior vice president of...
- Research articles 2002-07-22
- New focus
- The National Pharmaceutical Council has announced a new focus on evidence-based medicine for health care decision-making. The initiative will be the NPC's highest priority, notes Joseph Mahady, board chairman and president of global business for Wyeth Pharmaceuticals.
- Research articles 2007-09-17
- Wyeth Pharmaceuticals
- Joseph Mahady has been promoted to president, Wyeth Pharmaceuticals and senior vice president, Wyeth. He was previously president of global business for Wyeth Pharmaceuticals. Other promotions include Richard DeLuca, to president of veterinary medicines manufacturer and Wyeth subsidiary, Fort Dodge Animal Health. Cavan Redmond became president, Wyeth Consumer Healthcare and...
- Research articles 2007-12-24
- << Previous
- page 1 of 1
- Next >>
